Target intelligence / Profile preview

Immunoglobulin lambda-like polypeptide 1 (IGLL1)

Target
IGLL1
Molecular classification
Immunoglobulin gene superfamily, Surrogate light chain, Membrane protein
01

Overview

Immunoglobulin lambda-like polypeptide 1 (IGLL1) is a surrogate light chain component critical for early B-cell development, expressed primarily in pro-B and pre-B cells as part of the pre-B cell receptor complex. The protein enables B-cell differentiation, allelic exclusion of the immunoglobulin heavy chain, and facilitates immunoglobulin light chain gene rearrangements, all necessary steps for effective antibody production. IGLL1’s gene does not undergo immunoglobulin rearrangement, distinguishing it from typical immunoglobulin genes. Mutations in IGLL1 can cause autosomal recessive agammaglobulinemia, a severe B-cell deficiency resulting in very low antibody levels and immunodeficiency. Increased IGLL1 expression is associated with several B-cell malignancies, suggesting a possible biomarker role in leukemia and lymphoma diagnosis or prognosis. It belongs to the immunoglobulin gene superfamily and is membrane-bound in association with the pre-B cell receptor during early B-cell maturation.

Other names
CD179bCD179BIg lambda-5Immunoglobulin omega polypeptideImmunoglobulin-related protein 14.1IGL1IGL514.1IGVPBIGLJ14.1IGLLIGOPre-B lymphocyte-specific protein-2lambda 5AGM2VPREB2
02

Biological functions

B-cell developmentB-cell activationImmune responseImmunoglobulin productionCell proliferationCell differentiation
03

Disease associations

Agammaglobulinemia (Agammaglobulinemia 2, autosomal recessive)Chronic lymphocytic leukemiaMultiple myelomaWaldenstrom macroglobulinemiaNon-Hodgkin lymphoma
04

Biomarkers

Overexpression in B-cell malignancies (potential role in tumorigenesis and as a biomarker)

Beyond the preview

Go deeper on Immunoglobulin lambda-like polypeptide 1 (IGLL1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Immunoglobulin lambda-like polypeptide 1 (IGLL1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call